HeartFlow Gets New CPT Reimbursement Code for CT-Based Fraction Flow Reserve Analysis
The new Category I CPT code reportedly facilitates a nearly 7 percent increase in reimbursement for use of the CT-based fractional flow reserve assessment of coronary blood flow.
The American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT) code for the use of HeartFlow’s Fractional Flow Reserve CT (FFRCT) Analysis, which provides artificial intelligence (AI)-enabled assessment of coronary blood flow based on computed tomography (CT) scans.
The Category I CPT code, which went into effect on January 1, replaced four previous Category III CPT codes utilized for FFRCT, according to HeartFlow. The company said the new code will increase reimbursement for FFRCT Analysis by nearly seven percent in hospital settings.
In a recently issued guidance for 2024 changes to CPT codes, the AMA noted the new Category I CPT code for FFRCT Analysis can be utilized for capturing non-invasive estimates of coronary FFR values within the coronary tree and assessment of multiple and sequential lesions.
A newly issued Category I CPT code may increase reimbursement by nearly seven percent in hospital settings for HeartFlow’s Fractional Flow Reserve CT (FFRCT) Analysis (shown above). (Image courtesy of HeartFlow.)
The AMA guidance also notes CPT reimbursement coverage of ascertaining disease burden location and determining the lesion with the greatest hemodynamic significance in order to facilitate targeted treatment interventions, according to HeartFlow.
“This recognition emphasizes the value and importance of FFRCT Analysis to help clinicians accurately diagnose CAD in patients. Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients,” noted John Farquhar, the CEO of HeartFlow.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
